FMR CORP 13D/13G Filings for Xilio Therapeutics, Inc. (XLO)

FMR CORP 13D and 13G filings for Xilio Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-12
10:40 am
Sale		 2024-11-08 13G Xilio Therapeutics, Inc.
XLO		 FMR CORP 1,395,853
3.175%		 -511,818decrease
(-26.83%)		 Filing
2023-02-09
08:14 am
Sale		 2023-02-09 13G Xilio Therapeutics, Inc.
XLO		 FMR CORP 1,907,671
6.944%		 -662,599decrease
(-25.78%)		 Filing
2022-02-09
10:04 am
Sale		 2022-02-08 13G Xilio Therapeutics, Inc.
XLO		 FMR CORP 2,570,270
9.357%		 -87,400decrease
(-3.29%)		 Filing
2021-11-04
09:15 am
Purchase		 2021-11-04 13G Xilio Therapeutics, Inc.
XLO		 FMR CORP 2,657,670
9.966%		 2,657,670increase
(New Position)		 Filing